Airtime: ET
Imran Valibhoy, equities Analyst at Wise Owl recommends ResMed as a play for defensive investors. He explains why to CNBC.
A look ahead to the stories likely to make headlines next week, with CNBC's Michelle Caruso-Cabrera.
CNBC's Mary Thompson reports on the trading day from the NYSE.
A roundup of the week's business and financial news, with CNBC's Michelle Caruso-Cabrera.